SNTI

Senti Biosciences, Inc. Common Stock

1.11

USD

SNTI Earnings Reports

Positive Surprise Ratio

SNTI beat 7 of 8 last estimates.

88%

Next Report

Date of Next Report

Mar 18, 2026

Estimate for Q4 25 (Revenue/ EPS)

$680.00K

-$0.42

Implied change from Q3 25 (Revenue/ EPS)

-39.13%

Implied change from Q4 24 (Revenue/ EPS)

-37.31%

Senti Biosciences, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, SNTI reported earnings of -0.69 USD per share (EPS) for Q3 25, missing the estimate of -0.57 USD, resulting in a -19.38% surprise. Revenue reached --, compared to an expected 170.00 thousand, with a -100.00% difference. The market reacted with a -10.06% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.42 USD, with revenue projected to reach 680.00 thousand USD, implying an decrease of -39.13% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Senti Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Senti Biosciences, Inc. Common Stock reported EPS of -$0.69, missing estimates by -19.38%, and revenue of $0.00, -100% below expectations.

How did the market react to Senti Biosciences, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -10.06%, changed from $1.79 before the earnings release to $1.61 the day after.

When is Senti Biosciences, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 18, 2026.

What are the forecasts for Senti Biosciences, Inc. Common Stock's next earnings report?

Based on 6 analysts, Senti Biosciences, Inc. Common Stock is expected to report EPS of -$0.42 and revenue of $680.00K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.